Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network

Citation:
Gaggiano, C., D. Rigante, J. Hernández-Rodríguez, A. Vitale, M. Tarsia, A. Soriano, G. Lopalco, F. Iannone, M. Abdel Jaber, R. Giacomelli, et al., "Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network", Therapeutic Advances in Musculoskeletal Disease, vol. 13: SAGE Publications Ltd, 2021.

Abstract:

n/a

Notes:

Export Date: 26 July 2022Correspondence Address: Cantarini, L.; Research Center of Systemic Autoinflammatory Diseases, viale Bracci n. 1, Italy; email: cantariniluca@hotmail.com

Related External Link